| Ultrasound-mediated blood–brain barrier disruption for drug delivery: a systematic review of protocols, efficacy, and safety outcomes from preclinical and clinical studies K Gandhi, A Barzegar-Fallah, A Banstola, SB Rizwan, JNJ Reynolds Pharmaceutics 14 (4), 833, 2022 | 46 | 2022 |
| The neuroprotective effect of tropisetron on vincristine-induced neurotoxicity A Barzegar-Fallah, H Alimoradi, S Mehrzadi, N Barzegar-Fallah, ... Neurotoxicology 41, 1-8, 2014 | 45 | 2014 |
| Tropisetron ameliorates ischemic brain injury in an embolic model of stroke R Rahimian, A Daneshmand, SE Mehr, A Barzegar-Fallah, ... Brain research 1392, 101-109, 2011 | 44 | 2011 |
| Nitric oxide-releasing nanoparticles improve doxorubicin anticancer activity H Alimoradi, K Greish, A Barzegar-Fallah, L Alshaibani, V Pittalà International journal of nanomedicine, 7771-7787, 2018 | 43 | 2018 |
| Tropisetron ameliorates early diabetic nephropathy in streptozotocin‐induced diabetic rats A Barzegar‐Fallah, H Alimoradi, F Asadi, AR Dehpour, M Asgari, ... Clinical and experimental pharmacology and physiology 42 (4), 361-368, 2015 | 32 | 2015 |
| The cardioprotective effects of an antiemetic drug, tropisetron, on cardiomyopathy related to doxorubicin H Alimoradi, A Barzegar-Fallah, G Hassanzadeh, S Mohammadi-Rick, ... Cardiovascular toxicology 12, 318-325, 2012 | 25 | 2012 |
| Inhibition of calcineurin/NFAT pathway plays an essential role in renoprotective effect of tropisetron in early stage of diabetic nephropathy A Barzegar-Fallah, H Alimoradi, A Razmi, AR Dehpour, M Asgari, ... European journal of pharmacology 767, 152-159, 2015 | 22 | 2015 |
| Harnessing ultrasound for targeting drug delivery to the brain and breaching the blood–brain tumour barrier A Barzegar-Fallah, K Gandhi, SB Rizwan, TL Slatter, JNJ Reynolds Pharmaceutics 14 (10), 2231, 2022 | 18 | 2022 |
| Ipsilateral common iliac artery plus femoral artery clamping for inducing sciatic nerve ischemia/reperfusion injury in rats: a reliable and simple method M Nouri, R Rahimian, G Fakhfouri, MR Rasouli, S Mohammadi-Rick, ... Journal of brachial plexus and peripheral nerve injury 3 (1), 27, 2008 | 14 | 2008 |
| Steric stabilisers govern the colloidal and chemical stability but not in vitro cellular toxicity of linoleoylethanolamide cubosomes Y Mohammad, AB Fallah, JNJ Reynolds, BJ Boyd, SB Rizwan Colloids and Surfaces B: Biointerfaces 192, 111063, 2020 | 12 | 2020 |
| Encapsulation of tDodSNO generates a photoactivated nitric oxide releasing nanoparticle for localized control of vasodilation and vascular hyperpermeability H Alimoradi, A Barzegar-Fallah, IA Sammut, K Greish, GI Giles Free Radical Biology and Medicine 130, 297-305, 2019 | 9 | 2019 |
| Kelussia odoratissima Mozaff attenuates thromboembolic brain injury, possibly due to its Z-ligustilide content N Barzegar-Fallah, N Baery, M Soleymankhani, N Malekmohammadi, ... Brain Injury 30 (7), 926-932, 2016 | 9 | 2016 |
| Data characterizing the biophysical and nitric oxide release properties of the tDodSNO–Styrene maleic anhydride nanoparticle SMA-tDodSNO H Alimoradi, A Barzegar-Fallah, IA Sammut, K Greish, GI Giles Data in brief 21, 1771-1775, 2018 | 6 | 2018 |
| Pretreatment of CAV combination chemotherapy with tropisetron shows less cardio and neurotoxicity side effects in rats H Alimoradi, A Barzegar-Fallah, S Mohammadi-Rick, F Asadi, B Delfan, ... J. Clin. Toxicol. S 6, 2161-6, 2012 | 3 | 2012 |
| Serotonin type-3 receptor antagonists selectively kill melanoma cells through classical apoptosis, microtubule depolymerisation, ERK activation, and NF-κB … A Barzegar-Fallah, H Alimoradi, JL Dunlop, E Torbati, SK Baird Cell Biology and Toxicology, 1-17, 2021 | 2 | 2021 |
| Encapsulation of tDodSNO generates a nitric oxide releasing nanoparticle H Alimoradi, A Barzegar-Fallah, I Sammut, K Greish, G Giles Free Radical Biology and Medicine 128, S117, 2018 | 1 | 2018 |
| Gandhi et al. Ultrasound-Mediated Blood-Brain Barrier Disruption for Drug Delivery: A Systematic Review of Protocols, Efficacy, and Safety Outcomes from Preclinical and … K Gandhi, A Barzegar-Fallah, A Banstola, SB Rizwan, JNJ Reynolds PHARMACEUTICS 15 (1), 2023 | | 2023 |
| Correction: Gandhi et al. Ultrasound-Mediated Blood–Brain Barrier Disruption for Drug Delivery: A Systematic Review of Protocols, Efficacy, and Safety Outcomes from Preclinical … K Gandhi, A Barzegar-Fallah, A Banstola, SB Rizwan, JNJ Reynolds Pharmaceutics 15 (1), 5, 2022 | | 2022 |
| SMA-BmobaSNO: an intelligent photoresponsive nitric oxide releasing polymer for drug nanoencapsulation and targeted delivery H Alimoradi, A Thomas, DDB Lyth, A Barzegar-Fallah, SS Matikonda, ... Nanotechnology 33 (19), 195101, 2022 | | 2022 |
| From barriers to bridges; glycans in nonparenteral nanomedicines A Barzegar-fallah, J Houlton, D Barwick, A Shavandi, MA Ali, AN Clarkson, ... Theory and Applications of Nonparenteral Nanomedicines, 467-487, 2021 | | 2021 |
